Congenital Cardiac Anesthesia Society
A Section of the the Society for Pediatric Anesthesia

Congenital Cardiac Anesthesia Society

  • Member Login
  • Forgot Password?
  • Join
  • Home
  • About
    • Mission Statement
    • Bylaws
    • Board of Directors
    • History
    • Past Presidents
    • Charter Members
    • CCAS Lifetime Achievement Award
    • Mailing List Rental
    • Contact Us
  • Partners
    • SPA
    • SPPM
    • PALC
    • PCICS
    • AmSECT
    • SMACT
    • CHA
    • CCAN
  • Committees
    • CCAS Committees
      • Pediatric Cardiac Anesthesiology Program Director’s Group (PCAPD) Committee
      • Communications Committee
      • CCAS-STS Database Committee
      • Education Committee
      • Global Health Committee
      • Membership Committee
      • Quality and Safety Committee
      • Research Committee
    • CCAS Special Interest Groups
      • Adult Congenital Heart Disease Special Interest Group (SIG)
      • ERAS Special Interest Group (SIG)
      • Hemostasis Special Interest Group (SIG)
      • Latin America Special Interest Group (SIG)
      • Pulmonary Hypertension Special Interest Group (SIG)
      • Trainee Special Interest Group (SIG)
  • Membership
    • Benefits of Membership
    • CCAS Member App
    • Membership Categories
    • Join CCAS
      • Online Application
      • Printable Application
    • Renew Your Dues
    • Sponsor a Member
    • Get Involved
  • Meetings
    • Upcoming Meetings
    • Past Meetings
    • Other Meetings
    • Exhibit Information
  • Education
    • CCAS Virtual Visiting Professor Program
    • CCAS Webinar Series
      • CCAS Webinar Series – Recordings
    • CCAS COVID 19 Webinar
    • ACHD-SIG Anesthesia Rounds
    • Lecture Series
    • Echo Tutorial
    • Archived Questions
    • Poll of the Month Archives
    • Review Articles
      • CCAS-CHiP Network Journal Watch Collaboration
      • SCVA Articles
    • Journals of Interest
    • Books of Interest
    • Educational Links
  • Resources
    • CCAS Position Statements
    • CCAS Committee Resources
    • CCAS Special Interest Group (SIG) Resources
    • CCAS Cognitive Aids
    • Newsletters
    • Research Resources
    • Mission Trips
    • Societies
    • Job Opportunities
  • Research
    • Research Committee
    • CCAS 2025 Meeting Scholarship for Students and Residents
    • Research Network & Collaborative Opportunities
    • Research Resources
    • Dolly D. Hansen, MD Research Award
    • New for 2026! CCAS QI/Education Award
    • Podcast Series for Aspiring CCAS Researchers
    • Highlight on a CCAS Researcher
    • Call for Surveys
    • STS-CCAS Database
    • Donate to the Dolly Hansen Fund
  • Trainees
    • Introduction to Pediatric Cardiac Anesthesiology
    • Trainee Lecture Series
    • Advanced Training
    • Pediatric Cardiac Anesthesiology Fellowship Common Goals and Objectives
    • Frequently Asked Questions
    • Pediatric Cardiac Anesthesia Education Resources
    • Coaching/Mentoring Initiative
  • Patients
    • FAQs for Cardiac Anesthesia
    • FAQs for Cardiac Anesthesia – Spanish
    • SmartTots FAQs for Parents
    • Useful Resources for Parents

QOW 465

Author: Nicholas Houska, DO - University of Colorado - Children’s Hospital Colorado


An 8-day-old boy born with skeletal abnormalities, congenital heart disease, hypotonia, and facial dysmorphisms presents for cardiac surgery. Genetic testing reveals a pathogenic variant in the KMT2D gene consistent with a diagnosis of Kabuki syndrome. Which of the following types of congenital heart disease is MOST likely to be present?

Correct! Wrong!

EXPLANATION


First described in 1981, Kabuki syndrome is a heterogeneous disorder associated with multiple congenital defects including heart disease, developmental delay, hypotonia, renal malformations, skeletal anomalies, and distinct facial anomalies (laterally sparse and arched eyebrows, long palpebral fissures, large and everted ears, eversion of the lateral eyebrows, and pillowed lower lip).


Prior to 2010, the diagnosis of Kabuki syndrome was based on the phenotypic manifestations above. However, in 2010, the first and most common causative (55-80%) gene, KMT2D, was identified. Since then, three additional genes have been identified as pathogenic variants in a minority of Kubuki patients.


Retrospective studies describe the presence of congenital heart disease (CHD) in 58-70% of patients with Kabuki syndrome. In patients with Kabuki syndrome and CHD, the most common diagnoses are left-sided obstructive lesions (35-47%). The most common left-sided lesions include coarctation of the aorta (17.1%) and hypoplastic left heart syndrome (10.5%). Other left sided-obstructive lesions include aortic stenosis, mitral stenosis, and Shone’s complex. Septal defects are the next most common heart defects, either as a primary diagnosis or in conjunction with the above obstructive lesions. The remainder of children with Kabuki syndrome and CHD exhibit a heterogenous spectrum of cardiac lesions including conotruncal defects, atrioventricular canal defects, and right sided obstructive lesions. Of the identified genetic mutations associated with Kabuki syndrome, the KMT2D (MLL2) gene has been found to be most frequently associated with CHD.


As indicated above, left-sided obstructive lesions, such as coarctation of the aorta and Hypoplastic Left Heart Syndrome, are most commonly observed in patients with Kabuki syndrome versus Tetralogy of Fallot or Transposition of the Great Arteries.


REFERENCES


Yuan SM. Congenital heart defects in Kabuki syndrome. Cardiol J. 2013;20(2):121-4. doi: 10.5603/CJ.2013.0023. PMID: 23558868.


Digilio MC, Marino B, Toscano A, Giannotti A, Dallapiccola B. Congenital heart defects in Kabuki syndrome. Am J Med Genet. 2001 May 15;100(4):269-74. doi: 10.1002/ajmg.1265. PMID: 11343317.


Digilio MC, Gnazzo M, Lepri F et al.Congenital heart defects in molecularly proven Kabuki syndrome patients. Am J Med Genet A. 2017 Nov;173(11):2912-2922. doi: 10.1002/ajmg.a.38417. Epub 2017 Sep 8. PMID: 28884922.


Poll of the Month

May 2025
At your institution, do you routinely send a TEG/ROTEM during the rewarming phase of cardiopulmonary bypass?
View Results
Total Answers 81
Total Votes 81

Upcoming Meeting Information


CCAS 2026 Annual Meeting

March 12, 2026
Sheraton Denver Downtown
Denver, CO

 

 

 

 

Join CCAS
Renew
Donate
Get Involved
Upcoming
Job Postings
  • Member Login
  • Forgot Password?
2209 Dickens Road, Richmond, VA 23230 • 804-282-9780 • [email protected]
Copyright © 2025 The Congenital Cardiac Anesthesia Society | View Privacy Policy